BusinessAmerican Medical Association (AMA) Grants Exosome Diagnostics a CPT PLA Specific to Its ExoDx® Prostate(IntelliScore) TestBy Nasdaq OMXApr 26, 2017, 12:22 PM UTC
BusinessFirst U.S. Multi-center Investigational Clinical Trial of 177 Lu PSMA-617 Targeted Radioligand Therapy in Metastatic Castration Resistant Prostate Cancer Receives FDA ClearanceBy Nasdaq OMXFeb 6, 2017, 11:00 AM UTC
BusinessAmerican Health Council Names Luay Susan, M.D., to Physician BoardBy Nasdaq OMXJan 25, 2017, 4:32 PM UTC
BusinessHIFU Prostate Services Grows Experienced Team with Addition of Accomplished Urology Sales Representative Jenny H. RobesonBy Nasdaq OMXOct 21, 2016, 4:26 PM UTC
BusinessHIFU Prostate Services Expands Network of Experienced Physicians to Offer Non-Invasive Prostate Cancer Treatment in Raleigh, NCBy Nasdaq OMXSep 27, 2016, 3:19 PM UTC
